Now aromatase is a very bad enzyme because it converts free testosterone to estrogen.
Not exact matches
The
aromatase inhibitor is
now being tested in a clinical trial in France, led by Netchine, who has become a close collaborator and friend of Harbison's.
Breast cancer specialists are so concerned about all the estrogen women make after menopause that they
now use drugs to block the
aromatase enzyme.
I am dealing with autoimmune issues (PMR) for which I take a number of medications including prednisolone, severe osteoarthritis in both knees, and am 3 years post breast cancer having had all the chemo and radio therapy and am
now on
aromatase inhibitor therapy.